Search for: "Teva Pharmaceuticals"
Results 1281 - 1300
of 1,430
Sorted by Relevance
|
Sort by Date
27 Mar 2024, 10:56 am
” The majority cites the 2015 Federal Circuit decision in Momenta Pharmaceuticals v. [read post]
24 May 2010, 12:54 pm
”) In the latest lawsuit, MDCO and the PTO have filed cross-motions for summary judgment (here and here) and generic applicants Teva and APP Pharmaceuticals have filed amicus briefs (here and here). [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution … [read post]
19 Apr 2022, 5:05 am
Reg. 35952, 35958 (1991), See also OIG Compliance Program Guidance for Pharmaceutical Manufacturers, 66 Fed. [read post]
5 Nov 2017, 3:10 pm
Actavis and Teva appealed the decision on the '181 Patent on five grounds - construction/infringement, lack of entitlement to priority, added matter, novelty and obviousness. [read post]
24 Sep 2010, 1:22 pm
Patent No. 7,126,008 owned by Teva Pharmaceutical Industries Ltd. and entitled CARVEDILOL. [read post]
12 Nov 2009, 9:17 am
Teva Pharmaceuticals USA, Inc., 2007 WL 5787186, at *2-3 (S.D. [read post]
28 Sep 2016, 8:39 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
2 Jun 2011, 12:46 pm
Ortho Pharmaceutical Corp., 681 P.2d 1038, 1052 (Kan. 1984). [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop –… [read post]
5 Jan 2015, 1:26 pm
The prior published opinion in this case, Teva Pharmaceuticals USA, Inc. v. [read post]
12 Feb 2019, 11:30 am
Teva Pharmaceuticals USA Inc. [read post]
30 Sep 2010, 11:44 am
Teva, Cisco, and the Generic Pharma Association: The current standard creates an incentive for patent applicants to conceal material information from the USPTO. [read post]
15 Aug 2012, 11:02 am
According to Watson, “[b]ased on the simultaneous filing of the Watson ANDA with Mylan and Ranbaxy’s ANDAs, Watson has expected to share the period of 180-day exclusivity with Mylan and Ranbaxy (as well as with a fourth generic manufacturer, Teva Pharmaceuticals (‘Teva’), that has been granted a license by Takeda). [read post]
16 Feb 2015, 1:44 am
* "Fool's errand": no need to create your own brand if you can use someone else's Jeremy notes Speciality European Pharma Ltd v Doncaster Pharmaceuticals Group Ltd & Madaus GmbH [2015] EWCA Civ 54 [on which see earlier katpost here], a trade mark infringement decision of the Court of Appeal, England and Wales, on parallel importation and over-stickering of pharmaceutical products. [read post]
23 Feb 2015, 2:55 am
***** PREVIOUSLY, ON NEVER TOO LATE Never too late 33 [week ending Sunday 15 February] –- Evoking Audrey Hepburn’s image is not OK in Italy | Reasonable royalty and moral prejudice: new reference to the CJEU | CoA for England and Wales on parallel importations in Speciality European Pharma Ltd v Doncaster Pharmaceuticals Group Ltd & Madaus GmbH | The Logic of Innovation: Intellectual Property, and What the User Found There and Tritton on… [read post]
20 May 2013, 11:52 pm
Mylan concerning fexofenadine.The decision is by a 2-1 vote.The initial part of the decision:Aventis Pharmaceuticals, Inc. and Albany MolecularResearch, Inc. [read post]
10 Nov 2013, 6:37 am
"From IP to NP (Net Profit)" continued after a tasty and ample lunch break with a further parallel session, with the first pair of topics offered a choice between enforcing rights and getting them in the first place: 1 (for IP Professionals) Enforcement of IP Rights in US, Europe, Asia and Israel 2 (for entrepreneurs and IP managers) Seminar on IP Rights Registration in a Constantly Changing World, Part A: Claim Construction & Implications Again, this… [read post]
11 May 2015, 3:05 pm
******************PREVIOUSLY, ON NEVER TOO LATENever too late 44 [week ending on Sunday 3 May] – Forgotten principles and histories, and the role of complexity in patent law | King's College copyright distance learning Course | Spain, Berne, and the non-discrimination principle | Novartis v Focus, Actavis, Teva | SUEPO keeps demonstrating | Popcorn's blocking injunction | Unprecedented pre-action disclosure application in Arnoldian Big Bus v… [read post]
